{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:16:56Z","timestamp":1648783016145},"reference-count":13,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Ir. j. psychol. Med."],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec id=\"S0790966716000240_abs1\" sec-type=\"objectives\"><jats:title>Objectives<\/jats:title><jats:p>To compare benzodiazepine and z-hypnotic prescribing practices in an inpatient psychiatric unit to best practice standards.<\/jats:p><\/jats:sec><jats:sec id=\"S0790966716000240_abs2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>Medication charts of all inpatients in the psychiatric unit, over a 1-week period, were reviewed. Details of current benzodiazepine and z-hypnotic prescriptions were collected. Information collected included the substance prescribed, duration and administration instructions. Feedback was communicated to medical practitioners through a presentation and email. A re-audit was completed 4 months later.<\/jats:p><\/jats:sec><jats:sec id=\"S0790966716000240_abs3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>There were increases in total benzodiazepine and z-hypnotic prescribing despite intervention. A reduction of 2 mg occurred in the mean regular dose of benzodiazepine prescribed. Lorazepam was the most prescribed benzodiazepine throughout. In both data sets, at least 50% of regular z-hypnotics and benzodiazepines were initiated before admission. There was an increase of 14% in regular benzodiazepines initiated in hospital exceeding 4 weeks in duration. In neither data collection did regular z-hypnotics initiated in hospital exceed this cut off. A greater number of individuals were in the process of being withdrawn from regular benzodiazepine or z-hypnotic prescriptions in the re-audit. There were minimal improvements in \u2018as required\u2019 prescribing as regards documentation of an indication, time limit and maximum dose.<\/jats:p><\/jats:sec><jats:sec id=\"S0790966716000240_abs4\" sec-type=\"conclusion\"><jats:title>Conclusion<\/jats:title><jats:p>The increase in overall prescribing, despite intervention, maybe because these medications continued to be indicated in the acute presentations needing inpatient treatment. The small improvements in \u2018as required\u2019 prescribing patterns suggest that the intervention was limited in effecting change in this area.<\/jats:p><\/jats:sec>","DOI":"10.1017\/ipm.2016.24","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T05:47:12Z","timestamp":1466660832000},"page":"321-324","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["How do we compare with best practice? A completed audit of benzodiazepine and z-hypnotic prescribing"],"prefix":"10.1017","volume":"35","author":[{"given":"R.","family":"Rowntree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Crumlish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"key":"S0790966716000240_ref4","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.106.012328"},{"key":"S0790966716000240_ref200","article-title":"Use of psychotrophic drugs in special patient groups","author":"Taylor","year":"2012","journal-title":"The Maudsley Prescribing Guidelines in Psychiatry"},{"key":"S0790966716000240_ref3","unstructured":"College of Psychiatry of Ireland (2012). A consensus statement on the use of Benzodiazepines in specialist mental health services. EAP position paper. Dublin (http:\/\/www.irishpsychiatry.ie\/). Accessed 15 December 2015."},{"key":"S0790966716000240_ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106072386"},{"key":"S0790966716000240_ref2","volume-title":"Benzodiazepines: Good Practice Guidelines for Clinicians","year":"2002"},{"key":"S0790966716000240_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9096-0"},{"key":"S0790966716000240_ref9","unstructured":"Mental Health Commission (2010). Medication Report 2010. Ireland (http:\/\/www.mhcirl.ie\/Inspectorate_of_Mental_Health_Services\/Themed_Reports\/). Accessed 16 December 2015."},{"key":"S0790966716000240_ref8","unstructured":"Mental Health Commission (2009). Mental Health Commission Annual Report 2008 including report of the Inspector of Mental Health Services. Ireland (http:\/\/www.mhcirl.ie\/Publications\/Annual_Reports\/). Accessed 16 December 2015."},{"key":"S0790966716000240_ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448010-00004"},{"key":"S0790966716000240_ref10","volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2012"},{"key":"S0790966716000240_ref11","first-page":"401","article-title":"Consumption of benzodiazepines in a university hospital centre (in French)","volume":"18","author":"Vandel","year":"1992","journal-title":"Encephale"},{"key":"S0790966716000240_ref7","volume-title":"British National Formulary: BNF 69","year":"2015"},{"key":"S0790966716000240_ref5","first-page":"1","article-title":"Benzodiazepines and hypnotic prescribing in an acute adult psychiatric in-patient unit","volume":"33","author":"Hallahan","year":"2009","journal-title":"The Psychiatrist"}],"container-title":["Irish Journal of Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0790966716000240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T17:48:27Z","timestamp":1555091307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0790966716000240\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0790966716000240"],"URL":"https:\/\/doi.org\/10.1017\/ipm.2016.24","relation":{},"ISSN":["0790-9667","2051-6967"],"issn-type":[{"value":"0790-9667","type":"print"},{"value":"2051-6967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]},"assertion":[{"value":"\u00a9 College of Psychiatrists of Ireland 2016\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}